Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Early hemorrhage control isn’t just about stopping bleeding – it’s about improving patient outcomes.
Every minute of uncontrolled bleeding increases the risk of hemorrhagic shock, coagulopathy, organ dysfunction, greater transfusion requirements, and mortality. That’s why time to hemostasis is one of the most important factors in trauma and surgical care.
Our latest white paper explores how WoundClot supports early hemorrhage management across the continuum of care—from the point of injury and emergency departments to operating rooms, postoperative care, vascular access, and austere environments.
Key highlights include:
- Broad-spectrum use across appropriate accessible bleeding environments
- FDA-cleared in the U.S. as a hemostatic wound dressing and used internationally as a Class III implantable and bioresorbable surgical hemostat in over 50 countries
- More than a decade of clinical and commercial use with no reported product-related adverse events in company post-market surveillance
- A unique expanding gel-matrix technology that conforms to complex wounds, adheres to tissue, and helps create an effective localized hemostatic environment
- Evidence supporting the importance of earlier hemostasis in reducing mortality and major complications
The goal isn’t simply to stop bleeding – it’s to control hemorrhage early enough to prevent avoidable deterioration.
Every minute matters. Every drop counts.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026